aspect of
patent)
→
ReceivesAction
→
directed to sofosbuvir
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| specifically | 2 | manner |
| claim → be directed to → sofosbuvir | 3 |
| negative | neutral | positive |
| 0.361 | 0.615 | 0.025 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 90.904 |